What is the Nifty Pharma Index value today?
The latest value of Nifty Pharma Index is 22612.15 as of 17th December 2025.What is the shareholder returns of Nifty Pharma Index Index?
The Nifty Pharma Index has given the following returns in the past:- Past 1 week | 0.13%
- Past 1 month | -1.19%
- Past 3 months | 1.67%
- Past 6 months | 4.58%
- Past 1 year | 2.44%
- Past 3 years | 78.95%
- Past 5 years | 79.43%
What is the 52 week high value of Nifty Pharma Index?
The 52 week high value of Nifty Pharma Index is 23604.45, as of 17th December 2025.What is the 52 week low value of Nifty Pharma Index?
The 52 week low value of Nifty Pharma Index is 19121.10, as of 17th December 2025.What are the components of Nifty Pharma Index?
The components of Nifty Pharma Index, along with their weightage, are as follows -- Sun Pharmaceutical Industries Ltd | 23.88%
- Cipla Ltd | 10.47%
- Divi's Laboratories Ltd | 10.01%
- Dr Reddy's Laboratories Ltd | 9.34%
- Lupin Ltd | 6.39%
Nifty Pharma Index Today
NIFTY PHARMA Share Price
ETFs tracking NIFTY PHARMA
NIFTY PHARMA Performance & Key Metrics
NIFTY PHARMA Performance & Key Metrics
| PE RatioPE Ratio | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 35.07 | 5.41 | 0.71% |
| Market Cap ShareM Cap Share | ConstituentsConstituents | ETFsETFs |
|---|---|---|
| 3.69% | 20 | 1 |
About NIFTY PHARMA
About NIFTY PHARMA
Nifty Pharma Index is designed to reflect the behavior and performance of the pharmaceutical sector in India. The rescheduling of index constituents happens bi-annually every year.
Get more out of Tickertape, Go Pro!
Unlock exclusive stocks’ data & unlimited access with Tickertape Pro
Free float marketcap values in ₹ thousand cr.
| Stocks | 1D change | Return attribution | Index weight | Free float marketcap | |
|---|---|---|---|---|---|
| NIFTY PHARMA 1D return0.09% | 0.09% | 0.09% | 100.00% | Free float Mcap799.50 Weight100.00% | |
ABBOTINDIA 0.63% Return attribution-0.01% | 0.63% | -0.01% | 1.80% | 14.39 Weight1.80% | |
ALKEM 0.62% Return attribution-0.02% | 0.62% | -0.02% | 2.97% | 23.72 Weight2.97% | |
AJANTPHARM 0.16% Return attribution0.00% | 0.16% | 0.00% | 1.37% | 10.92 Weight1.37% | |
BIOCON 0.31% Return attribution0.01% | 0.31% | 0.01% | 2.93% | 23.41 Weight2.93% | |
AUROPHARMA 1.26% Return attribution0.05% | 1.26% | 0.05% | 3.98% | 31.82 Weight3.98% | |
DRREDDY 0.38% Return attribution-0.04% | 0.38% | -0.04% | 9.34% | 74.66 Weight9.34% | |
ZYDUSLIFE 0.41% Return attribution0.01% | 0.41% | 0.01% | 2.87% | 22.95 Weight2.87% | |
DIVISLAB 0.67% Return attribution-0.07% | 0.67% | -0.07% | 10.01% | 80.06 Weight10.01% | |
CIPLA 0.18% Return attribution-0.02% | 0.18% | -0.02% | 10.47% | 83.69 Weight10.47% | |
GLENMARK 0.92% Return attribution-0.03% | 0.92% | -0.03% | 3.44% | 27.46 Weight3.44% | |
IPCALAB 2.50% Return attribution-0.06% | 2.50% | -0.06% | 2.43% | 19.46 Weight2.43% | |
J B Chemicals and Pharmaceuticals Ltd JBCHEPHARM 0.66% Return attribution0.01% | 0.66% | 0.01% | 1.83% | 14.64 Weight1.83% | |
LUPIN 1.08% Return attribution0.07% | 1.08% | 0.07% | 6.39% | 51.10 Weight6.39% | |
LAURUSLABS 0.87% Return attribution0.04% | 0.87% | 0.04% | 4.63% | 36.99 Weight4.63% | |
Sun Pharmaceutical Industries Ltd SUNPHARMA 0.65% Return attribution0.16% | 0.65% | 0.16% | 23.88% | 190.95 Weight23.88% | |
TORNTPHARM 0.15% Return attribution0.01% | 0.15% | 0.01% | 4.66% | 37.28 Weight4.66% | |
WOCKPHARMA 0.13% Return attribution0.00% | 0.13% | 0.00% | 1.35% | 10.82 Weight1.35% | |
GLAND 0.70% Return attribution-0.01% | 0.70% | -0.01% | 1.64% | 13.11 Weight1.64% | |
PPLPHARMA 0.42% Return attribution-0.01% | 0.42% | -0.01% | 1.26% | 10.07 Weight1.26% | |
MANKIND 0.25% Return attribution0.01% | 0.25% | 0.01% | 2.75% | 22.01 Weight2.75% |
ETFs tracking NIFTY PHARMA Index
ETFs tracking NIFTY PHARMA Index
| ETFs | Price | Liquidity | Expense ratio | Tracking error | |
|---|---|---|---|---|---|
PHARMABEES — | — | High | 0.21% | 0.01% |
NIFTY PHARMA Events
NIFTY PHARMA Events
Dividends
Corp. Actions
Announcements
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
NIFTY PHARMA Upcoming Dividends
NIFTY PHARMA Upcoming Dividends
No upcoming dividends are available
NIFTY PHARMA Past Dividends
NIFTY PHARMA Past Dividends
Cash DividendAJANTPHARM
AJANTPHARMEx DateEx DateNov 10, 2025
Dividend/Share
₹28.00
Ex DateEx Date
Nov 10, 2025
Cash DividendLAURUSLABS
LAURUSLABSEx DateEx DateOct 31, 2025
Dividend/Share
₹0.80
Ex DateEx Date
Oct 31, 2025
Cash DividendGLENMARK
GLENMARKEx DateEx DateOct 3, 2025
Dividend/Share
₹2.50
Ex DateEx Date
Oct 3, 2025
Cash DividendGLENMARK
GLENMARKEx DateEx DateSep 15, 2025
Dividend/Share
₹2.50
Ex DateEx Date
Sep 15, 2025
Cash DividendGLAND
GLANDEx DateEx DateAug 14, 2025
Dividend/Share
₹18.00
Ex DateEx Date
Aug 14, 2025
NIFTY PHARMA News & Opinions
NIFTY PHARMA News & Opinions
Trial by fire: Over 60% of pharma SMEs may be forced to shut shop
1 day ago•Economic Times
Market Trading Guide: Buy Indian Metals and a smallcap stock on Tuesday for up to 14% gains - Stock Ideas
2 days ago•Economic Times
Gainers & Losers: PVR Inox, Urban Company among 8 stocks that moved most on Monday
2 days ago•Economic Times
Sensex, Nifty End Slightly Lower After Early Recovery, Weak Global Signals Keep Investors Careful
2 days ago•Free Press Journal
Watch Lupin, Dr Reddy’s, Aurobindo, Biocon stocks today (Dec 15)
2 days ago•The Hindu Businessline
Piramal Pharma shares in focus after USFDA issues form 483 for Kentucky unit
5 days ago•Economic Times
Corona Remedies IPO Allotment Status Live : Indian pharmaceutical industry valued at ₹4.5 trillion in FY 2025 - The Economic Times
6 days ago•Economic Times
Pick of Portfolio - December 7, 2025
1 week ago•The Hindu Businessline
Pharma OTT release date: Nivin Pauly’s debut series trailer out. When and where to watch Malayalam medical thriller online
1 week ago•Economic Times
Sun Pharma shares in focus after board approves Rs 3,000 crore investment
2 weeks ago•Economic Times